December Rosa Webinar

Applications of Minimal PBPK Models to Small and Large Molecules by Dr. Yanguang Cao Research Assistant Professor Department of Pharmaceutical Sciences State University of New York at Buffalo Buffalo, NY December 11, 2013 1:00 - 2:00 pm EST Dr. Cao's webinar "Applications of Minimal PBPK Models to Small and Large Molecules" will take place on Wednesday, December 11, 2013 at 1:00 pm - 2:00 pm EST. >From Dr. Cao, "Minimal PBPK model is an intermediate modeling approach between >full-PBPK model and mammillary model. This modelling approach is conceptually >developed by substantially lumping full PBPK model. Most importantly, minimal >PBPK model provides a sensible modeling approach when fitting ONLY plasma (or >blood) data but yielding physiologically-relevant PK parameters. These >parameters may provide more practical value than that generated in mammillary >models. This talk will be about applying this modeling approach to both small >molecules and monoclonal antibodies PK analysis." Dr. Cao's presentation is a part of the monthly world-wide webinar series "Impact of Modeling & Simulation in Drug Development" hosted by Rosa & Co. LLC. The purpose of the "Impact" series is to foster the use of M&S activities in all phases of drug development by illustrating the advantages and enhancing the applicability of M&S in product discovery, development, and marketing programs. The series is intended for drug development project team members from discovery to phase IV clinical trials. This includes pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinical development team members, regulatory affairs specialists, and other interested professionals. Register for this free webinar at www.rosaandco.com/webinar. After registering you will receive a confirmation email containing information about joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at http://www.rosaandco.com/webinar. Toufigh Gordi, PhD President, PK/PD and Clinical Pharmacology Services Direct: 408-480-7314 Corp: 408-370-9800 Fax: 408-370-9810 [email protected]